Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
See Latest ArticlesAnalysis of mortality following a mass immunization campaign with serogroup C meningococcal conjugate vaccine: Methodological difficulties and imperfect solutions
Vaccine , 06/03/09
Wals PD et al. - All cause mortality was more than three times higher in the control group than in the C-MCV group, and the excess was seen for all major categories of causes. Two time-clusters were detected in the C-MCV group, but none of them appeared to be plausibly related to the administration of C-MCV. In the C-MCV group, there was no death caused by meningococcal disease, Guillain–Barré syndrome, anaphylactic shock, or a complication of vaccination.
Today in Neurologic/Ophthalmic...keeping you current
Receive free subspecialty "5-minute updates" via email
Review: Cyclophosphamide in multiple sclerosis: scientific rationale, history and novel treatment paradigms
Therapeutic Advances in Neurological Disorders, 11/10/09
The management of allergic eye diseases in primary eye care
Contact Lens and Anterior Eye, 11/03/09
Autoimmune Targets of Heart and Skeletal Muscles in Myasthenia Gravis
Archives of Neurology, 11/19/09
Today in Vaccine/Immunotherapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Update on vaccination guidelines for allergic children
Expert Review of Vaccines, 10/29/09
Safety of vaccination of patients with systemic lupus erythematosus
Lupus, 11/04/09
Yearly influenza vaccinations: a double-edged sword
The Lancet Infectious Diseases, 11/19/09
Sponsor
Article Search
Sponsor